Turin, Italy

Francesco Novelli

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Torino, IT (2011)
  • Turin, IT (2014)

Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Francesco Novelli: Innovator in Cancer Diagnosis and Treatment

Introduction

Francesco Novelli is a prominent inventor based in Turin, Italy. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of pancreatic adenocarcinoma. With a total of 2 patents, Novelli's work focuses on innovative solutions that can potentially improve patient outcomes.

Latest Patents

Francesco Novelli's latest patents include groundbreaking inventions that target pancreatic adenocarcinoma. One of his patents describes an isolated monophosphorylated peptide derived from human alpha-enolase, which is useful for diagnosis and treatment. This peptide, consisting of 12-20 amino acids, features a phosphorylated serine residue at position 8. Additionally, he has developed antibodies that specifically bind to this peptide and the phosphorylated isoform of alpha-enolase, which may be utilized in diagnosing and treating pancreatic adenocarcinoma. Another patent focuses on novel human protein antigens and related antibodies that are specifically expressed in association with pancreatic ductal adenocarcinoma. These discoveries have the potential to enhance diagnostic accuracy and therapeutic strategies for this aggressive cancer.

Career Highlights

Throughout his career, Francesco Novelli has worked with various companies, including Ribovax Biotechnologies and Bioline Diagnostici. His expertise in biotechnology and cancer research has positioned him as a key figure in the development of innovative diagnostic tools and treatments.

Collaborations

Francesco Novelli has collaborated with notable professionals in his field, including Barbara Tomaino and Paola Cappello. These partnerships have contributed to the advancement of research and the successful development of his patented technologies.

Conclusion

Francesco Novelli's contributions to cancer research, particularly in the area of pancreatic adenocarcinoma, highlight his innovative spirit and dedication to improving patient care. His patents represent significant advancements in the diagnosis and treatment of this challenging disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…